Having trouble finding Afinitor (Everolimus) at your pharmacy? Learn why this cancer medication can be hard to find in 2026 and what you can do about it.
If you or someone you love has been prescribed Afinitor, you may have run into a frustrating problem: your pharmacy doesn't have it in stock. You're not alone. Many patients across the country are struggling to fill their Afinitor prescriptions, and the reasons go beyond a simple supply shortage.
In this guide, we'll explain what Afinitor is, why it's so difficult to find at pharmacies in 2026, and — most importantly — what you can do to get your medication without dangerous gaps in treatment.
Afinitor (generic name: Everolimus) is a prescription medication made by Novartis. It belongs to a class of drugs called mTOR inhibitors, which work by blocking a protein called mTOR that helps cancer cells grow and divide. By shutting down this protein, Afinitor slows or stops tumor growth.
Afinitor is FDA-approved to treat several serious conditions, including:
It comes as a tablet (2.5 mg, 5 mg, 7.5 mg, and 10 mg) and as a dispersible tablet for oral suspension called Afinitor Disperz (2 mg, 3 mg, 5 mg). For more details on the drug itself, see our complete guide: What Is Afinitor? Uses, Dosage, and What You Need to Know.
Afinitor isn't something your local CVS or Walgreens typically keeps on the shelf. It's classified as a specialty medication, which means it's expensive, requires special handling and storage, and is usually dispensed through specialty pharmacies. Most retail pharmacies simply don't stock it because demand at any single location is low and the cost of carrying inventory is extremely high — a single 28-day supply of brand-name Afinitor costs between $18,413 and $19,260.
Because Afinitor is a specialty drug, Novartis and insurance companies often require it to be dispensed through designated specialty pharmacies. This means even if your neighborhood pharmacy could order it, your insurance plan may not allow them to fill it. You may be required to use a specific mail-order or specialty pharmacy, which can add delays.
Nearly every insurance plan requires prior authorization before covering Afinitor. This means your doctor has to submit paperwork proving the medication is medically necessary for your specific condition. The process can take days or even weeks, and denials are common — especially if step therapy requirements haven't been met. While this isn't technically a supply problem, it creates real delays in getting your medication.
Even when generic Everolimus is available, not every strength or formulation may be in stock. If your prescription calls for the 7.5 mg tablet or the Afinitor Disperz dispersible tablet, availability can be more limited. Generic manufacturers may not produce every strength, and the Disperz formulation has fewer generic options.
Don't wait until you're completely out of medication to start looking. Here are practical steps you can take right now:
Medfinder lets you search for Afinitor availability at pharmacies near you in real time. Instead of calling pharmacy after pharmacy, you can see which locations have it in stock and compare your options. It's free and takes just a few seconds.
Generic Everolimus tablets are now available from multiple manufacturers and can cost as little as $90 per month with discount cards — a massive savings compared to $18,000+ for the brand. Ask your doctor if generic Everolimus is appropriate for your situation. Learn more in our savings guide: How to Save Money on Afinitor in 2026.
If your insurance requires a specialty pharmacy, call them directly to confirm they have your specific strength in stock and ask about expected delivery times. Many specialty pharmacies can ship directly to your home.
Your doctor's office may have relationships with specialty pharmacies that keep Afinitor in stock, or they may have samples available to bridge a gap. They can also help expedite prior authorization if that's what's causing the delay.
If cost is the barrier, the Novartis Patient Assistance Foundation provides Afinitor at no cost to eligible patients who are uninsured or can't afford it. Commercially insured patients may qualify for the Novartis Oncology Universal Co-pay Program, which can reduce out-of-pocket costs to $0 (up to $15,000 per year). Learn more about these options in our complete guide to saving money on Afinitor.
If you've tried everything and still can't get your hands on Afinitor, it may be time to talk to your doctor about alternative medications. Depending on your condition, options may include other mTOR inhibitors like Temsirolimus (Torisel) or different targeted therapies. Never stop taking Afinitor or change your dose without talking to your doctor first.
Finding Afinitor in 2026 can be challenging, but it's not impossible. The key is to understand why it's hard to find — specialty distribution, insurance barriers, and formulation-specific stock issues — and then take proactive steps to secure your supply. Tools like Medfinder can save you hours of phone calls, and programs from Novartis can help with the cost.
Your health shouldn't have to wait because of pharmacy logistics. Start your search today and take control of your treatment.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
